Acute pancreatitis (AP) is an inflammatory condition of the pancreas that ranges from mild, selflimiting disease to severe, lifethreatening illness with multiorgan failure. The metabolic stress of AP, coupled with the risk of intestinal barrier breakdown, makes nutrition a pivotal component of management. Over the past two decades, evidence has shifted the paradigm from routine bowel rest toward early enteral nutrition (EN) whenever possible.
Patients with AP often experience nausea, vomiting, abdominal pain, and reduced oral intake. Prolonged fasting can lead to:
These complications are directly linked to worse outcomes, including longer intensivecare stays and higher mortality. Early provision of nutrients, especially via the gastrointestinal tract, helps preserve gut integrity, modulate the inflammatory response, and reduce infectious complications.
Enteral nutrition (EN) delivers nutrients directly into the lumen of the gastrointestinal (GI) tract, typically through a nasogastric (NG) or nasojejunal (NJ) tube. Parenteral nutrition (PN) bypasses the GI tract, supplying nutrients intravenously.
Key advantages of EN over PN in AP include:
Guidelines from the American Gastroenterological Association (AGA), the International Association of Pancreatology (IAP), and the European Society for Clinical Nutrition and Metabolism (ESPEN) now recommend early EN (within 2448h of admission) for most patients with AP, unless a clear contraindication exists.
EN should be considered in any patient with:
In patients with mild AP who can tolerate a regular diet within 24h, early oral feeding is acceptable and may be preferable.
Historically, many clinicians favored NJ tubes to bypass pancreatic stimulation. Recent randomized trials, however, have shown that NG feeding is equally effective in most cases, provided the patient does not have marked gastric outlet obstruction or severe vomiting.
**Practical recommendations**:
Standard polymeric formulas are the first choice for most patients. They contain intact proteins, complex carbohydrates, and longchain triglycerides (LCTs) and are well tolerated.
Specialized formulas may be considered in selected scenarios:
1. **Start low, go slow** Begin at 1020mL/h and increase by 1020mL/h every 46h as tolerated.
2. **Monitor tolerance** Assess abdominal distension, gastric residuals (if NG), bowel sounds, and signs of aspiration.
3. **Target caloric goal** 2530kcal/kg/day is reasonable; protein 1.21.5g/kg/day.
4. **Duration** Continue EN until the patient can meet >60% of energy needs orally for at least 48h.
Several landmark trials have shaped current practice:
Enteral nutrition is a cornerstone of modern management of acute pancreatitis. Early initiation, preferably via a nasogastric tube with a standard polymeric formula, improves clinical outcomes by preserving gut barrier function, limiting systemic inflammation, and reducing infectious complications. While individual patient factors may necessitate adjustmentssuch as using a nasojejunal route or specialized formulasthe overarching message is clear: feed early, feed enterally whenever it is safe to do so.
For further reading, consult the latest AGA and ESPEN guidelines, and stay updated with emerging data on immunonutrition and personalized feeding strategies.
